✦ LIBER ✦

The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib

✍ Scribed by Miething, C; Feihl, S; Mugler, C; Grundler, R; von Bubnoff, N; Lordick, F; Peschel, C; Duyster, J

Book ID: 110056672
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 340 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404151

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increasing the BCR-ABL expression levels

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia

✍ S. Grammatico; L. Elia; A.L. Peluso; L. Pedace; M. Matarazzo; A. Vitale; A. Rago 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Heterozygous mutations in the FGF8, SHH

Heterozygous mutations in the FGF8, SHH and nodal/transforming growth factor beta pathways do not confer increased dopaminergic neuron vulnerability—A zebrafish study

✍ Christine Lo; Laura J. Flinn; Oliver Bandmann 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Drug resistance and BCR-ABL kinase domai

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the fr

✍ Soverini, Simona; De Benedittis, Caterina; Papayannidis, Cristina; Paolini, Stef 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Fusion of the BCR and the fibroblast gro

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

✍ Thoas Fioretos; Ioannis Panagopoulos; Carin Lassen; Agneta Swedin; Rolf Billströ 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract Constitutive activation of tyrosine kinases as a consequence of chromosomal translocations, forming fusion genes, plays an important role in the development of hematologic malignancies, in particular, myeloproliferative syndromes (MPSs). In this respect, the t(9;22)(q34;q11) that result